Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2007 1
2008 1
2013 4
2014 4
2015 2
2016 2
2017 13
2018 20
2019 36
2020 61
2021 67
2022 22
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. He J, et al. Among authors: chen j. Ann Rheum Dis. 2020 Jan;79(1):141-149. doi: 10.1136/annrheumdis-2019-215396. Epub 2019 Sep 19. Ann Rheum Dis. 2020. PMID: 31537547 Free PMC article. Clinical Trial.
Time-varying effects of FOXA1 on breast cancer prognosis.
Chen QX, Yang YZ, Liang ZZ, Chen JL, Li YL, Huang ZY, Weng ZJ, Zhang XF, Guan JX, Tang LY, Yun JP, Ren ZF. Chen QX, et al. Breast Cancer Res Treat. 2021 Jun;187(3):867-875. doi: 10.1007/s10549-021-06125-7. Epub 2021 Feb 18. Breast Cancer Res Treat. 2021. PMID: 33604715
205 results